| Literature DB >> 32860165 |
Lucas Buzeli de Souza1, Jennyffer Ione de Souza Silva1, Leonardo Bagne1, Amanda Tavares Pereira1, Maraiara Aparecida de Oliveira1, Bruno Bellotti Lopes2, Maria Esméria Corezola do Amaral1, Andrea Aparecida de Aro1, Marcelo Augusto Marretto Esquisatto1, Gláucia Maria Tech Dos Santos1, Thiago Antônio Moretti de Andrade3.
Abstract
Burns are a public health problem, with second-degree burns as one of the most common types. Although intense inflammation worsens burn healing, effective therapies are scarce. Thus, infections and hypertrophic scars may occur, which compromise patient quality of life and may delay healing. Argon atmospheric plasma (AP) has been shown to positively influence wound healing. In the context of identifying effective and alternative therapies for the treatment of second-degree burns, the present study evaluated AP in the treatment of second-degree burns in rats compared to that for sham treatment on the 2nd, 7th, 14th, and 21st days post-injury. Our results revealed proinflammatory effect for AP by recruiting predominantly neutrophils on the 7th day and macrophages on the 21st day compared to sham treatment, allowing a greater production of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and IL-17, and also controlled the inflammation by IL-10 and transforming growth factor (TGF)-β1. AP also showed antioxidant activity important for controlling oxidative damage on the 2nd day. This favored the induction of angiogenesis from the 2nd day and induction fibroplasia and fibrillogenesis after the 14th day, which enhanced burn healing with the formation of a thinner burn eschar before the 21st day post-burn. Thus, AP effectively modulated the inflammatory phase of second-degree burn healing through the control of oxidative damage that favored the following phases. Therefore, AP is a relevant alternative in the treatment of second-degree burns.Entities:
Keywords: angiogenesis; antioxidant; argon atmospheric plasma; collagen type I; inflammation; second-degree burn
Mesh:
Substances:
Year: 2020 PMID: 32860165 DOI: 10.1007/s10753-020-01305-x
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092